- Conditions
- Duchene Muscular Dystrophy
- Interventions
- Not listed
- Lead sponsor
- ITF Therapeutics LLC
- Industry
- Eligibility
- 6 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 9
- States / cities
- Little Rock, Arkansas • Washington D.C., District of Columbia • Chicago, Illinois + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Polycythemia Vera
- Interventions
- Givinostat, Hydroxyurea
- Drug
- Lead sponsor
- Italfarmaco
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Redlands, California • Englewood, Colorado + 10 more
- Conditions
- Duchenne Muscular Dystrophy (DMD)
- Interventions
- Not listed
- Lead sponsor
- Red Nucleus Enterprise Solutions, LLC
- Industry
- Eligibility
- 10 Years and older · Male only
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Yardley, Pennsylvania
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Givinostat
- Drug
- Lead sponsor
- Italfarmaco
- Industry
- Eligibility
- 7 Years and older · Male only
- Enrollment
- 206 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2029
- U.S. locations
- 10
- States / cities
- Sacramento, California • San Diego, California • Hartford, Connecticut + 7 more
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- givinostat, placebo
- Drug
- Lead sponsor
- Italfarmaco
- Industry
- Eligibility
- 6 Years to 17 Years · Male only
- Enrollment
- 179 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 13
- States / cities
- Davis, California • San Diego, California • Aurora, Colorado + 10 more